HUTCHMED (China) (HK:0013)
HK$23.86-0.42 (-1.73%)
HK:0013
HUTCHMED (China) stock forecast
HK$23.86
At close:-0.42 (-1.73%)
Want to see HK:0013 full AI Analyst Report?
HUTCHMED (China) (0013) Stock Forecast & Price Target
8 Followers
0013 Analyst Ratings
Strong Buy
10Buy0Hold0Sell
Based on 10 analysts giving stock ratings to HUTCHMED (China) in the past 3 months
0013 Stock 12 Month Forecast
Average Price Target
HK$31.68▲(32.77% Upside)Based on 10 Wall Street analysts offering 12 month price targets for HUTCHMED (China) in the last 3 months. The average price target is HKD 31.68 with a high forecast of HKD 43.20 and a low forecast of HKD 17.40. The average price target represents a 32.77% change from the last price of HKD 23.86.
Past 12 Months12 Month ForecastJan2026Oct2026
HighHK$43.20
AverageHK$31.68
LowHK$17.40
Highest Price TargetHighestHK$43.20Average Price TargetHK$31.68Lowest Price TargetLowestHK$17.40
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | BOCOM International Holdings Company | HK$37.45 | buy | 56.96%Upside | Reiterated | 11/10/26 | ||
| Unknown AnalystNot Ranked | Citi | HK$39→HK$43.20 | buy | 81.06%Upside | Reiterated | 11/06/26 | ||
| Unknown AnalystNot Ranked | Orient Securities | HK$29.79→HK$27.44 | buy | 15.00%Upside | Reiterated | 11/01/26 | ||
| Unknown AnalystNot Ranked | GF Securities | HK$31.54→HK$31.42 | buy | 31.68%Upside | Reiterated | 10/30/26 | ||
| Unknown AnalystNot Ranked | Huatai Securities | HK$33.49 | buy | 40.36%Upside | Reiterated | 10/28/26 | ||
| Unknown AnalystNot Ranked | CICC | HK$28 | buy | 17.35%Upside | Reiterated | 10/27/26 | ||
| Cindy Chai | HSBC | HK$17.40 | buy | -27.07%Downside | Upgraded | 09/08/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | HK$36→HK$38 | buy | 59.26%Upside | Reiterated | 09/07/26 | ||
| Unknown AnalystNot Ranked | Daiwa | HK$20→HK$28.50 | buy | 19.45%Upside | Upgraded | 09/03/26 | ||
| Unknown AnalystNot Ranked | Sinolink Securities | HK$31.90 | buy | 33.70%Upside | Reiterated | 08/21/26 | ||
| Unknown AnalystNot Ranked | UBS | HK$34.10→HK$29.50 | buy | 23.64%Upside | Reiterated | 07/31/26 | ||
| Unknown AnalystNot Ranked | Guotai Haitong | HK$35.58 | buy | 49.12%Upside | Reiterated | 07/31/26 | ||
| Unknown AnalystNot Ranked | UOB Kay Hian | HK$26 | buy | 8.97%Upside | Reiterated | 07/31/26 | ||
| Unknown AnalystNot Ranked | Goldman Sachs | HK$21.84 | hold | -8.47%Downside | Reiterated | 07/30/26 | ||
| Jack Lin | Morgan Stanley | HK$21.30 | hold | -10.73%Downside | Reiterated | 05/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystBOCOM International Holdings CompanyNot Ranked | BuyReiteratedHK$37.45 | 11/10/26 | 56.96%Upside | ||
| Unknown AnalystCitiNot Ranked | BuyReiteratedHK$39→HK$43.20 | 11/06/26 | 81.06%Upside | ||
| Unknown AnalystOrient SecuritiesNot Ranked | BuyReiteratedHK$29.79→HK$27.44 | 11/01/26 | 15.00%Upside | ||
| Unknown AnalystGF SecuritiesNot Ranked | BuyReiteratedHK$31.54→HK$31.42 | 10/30/26 | 31.68%Upside | ||
| Unknown AnalystHuatai SecuritiesNot Ranked | BuyReiteratedHK$33.49 | 10/28/26 | 40.36%Upside | ||
| Unknown AnalystCICCNot Ranked | BuyReiteratedHK$28 | 10/27/26 | 17.35%Upside | ||
| Cindy ChaiHSBC | BuyUpgradedHK$17.40 | 09/08/26 | -27.07%Downside | ||
| Unknown AnalystCitic SecuritiesNot Ranked | BuyReiteratedHK$36→HK$38 | 09/07/26 | 59.26%Upside | ||
| Unknown AnalystDaiwaNot Ranked | BuyUpgradedHK$20→HK$28.50 | 09/03/26 | 19.45%Upside | ||
| Unknown AnalystSinolink SecuritiesNot Ranked | BuyReiteratedHK$31.90 | 08/21/26 | 33.70%Upside | ||
| Unknown AnalystUBSNot Ranked | BuyReiteratedHK$34.10→HK$29.50 | 07/31/26 | 23.64%Upside | ||
| Unknown AnalystGuotai HaitongNot Ranked | BuyReiteratedHK$35.58 | 07/31/26 | 49.12%Upside | ||
| Unknown AnalystUOB Kay HianNot Ranked | BuyReiteratedHK$26 | 07/31/26 | 8.97%Upside | ||
| Unknown AnalystGoldman SachsNot Ranked | HoldReiteratedHK$21.84 | 07/30/26 | -8.47%Downside | ||
| Jack LinMorgan Stanley | HoldReiteratedHK$21.30 | 05/28/26 | -10.73%Downside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering HUTCHMED (China)
3 Months
Success Rate0/2 ratings generated profit
0%
Average Return
-6.40%
Copying xAi Health Care GB's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -6.40% per trade.
1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-6.40%
Copying xAi Health Care GB's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -6.40% per trade.
2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-6.40%
Copying xAi Health Care GB's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.40% per trade.
0013 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 6 | 10 | 12 | 10 | 7 |
| Buy | 1 | 3 | 6 | 6 | 5 |
| Hold | 2 | 2 | 2 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 9 | 15 | 20 | 17 | 12 |
In the current month, 0013 has received 12 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0013 average Analyst price target in the past 3 months is 31.68.
0013 Financial Forecast
HighHK$0.31
ConsensusHK$0.31
LowHK$0.31
0013 Earnings Forecast
Next quarter’s earnings estimate for 0013 is HKD 0.31 with a range of HKD 0.31 to HKD 0.31. The previous quarter’s EPS was HKD 0.16. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighHK$2.36B
ConsensusHK$2.36B
LowHK$2.36B
0013 Sales Forecast
Next quarter’s sales forecast for 0013 is HKD 2.36B with a range of HKD 2.36B to HKD 2.36B. The previous quarter’s sales results were HKD 2.18B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
0013 Stock Forecast FAQ
What is HK:0013’s average 12-month price target, according to analysts?
Based on analyst ratings, HUTCHMED (China) ’s 12-month average price target is HK$31.68.
What is HK:0013’s upside potential, based on the analysts’ average price target?
HUTCHMED (China) has 32.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HUTCHMED (China) a Buy, Sell or Hold?
HUTCHMED (China) has a consensus rating of Strong Buy, which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.
What is HUTCHMED (China) ’s share price target?
The average share price target for HUTCHMED (China) is HK$31.68. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$43.20, and the lowest forecast is HK$17.40. The average share price target represents a 32.77% increase from the current price of HK$23.86.
What do analysts say about HUTCHMED (China) ?
HUTCHMED (China) ’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of HUTCHMED (China) ?
To buy shares of HK:0013, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
